A critical advance in cancer investigation is occurring with the use of VHH fragments to reactivate damaged p53. This vital malignant protector protein is frequently lost in several types of tumors, resulting https://adsbookmark.com/story22064563/mini-antibodies-reactivate-the-p53-protein-new-new-hope-for-malignant-management